Clinical Trials
50 trialsNatural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
National Institutes of Health Clinical Center (CC)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
National Institutes of Health Clinical Center (CC)
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Center for International Blood and Marrow Transplant Research
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
PERSIST
AvenCell Therapeutics, Inc.
LTFS
Caribou Biosciences, Inc.
Aquarius
Tempus AI
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Children's Hospital Medical Center, Cincinnati
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
Clinical Cohort of Lymphoma Patients in Malawi
UNC Lineberger Comprehensive Cancer Center
Besponsa Post Marketing Surveillance Study
Pfizer
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
National Institutes of Health Clinical Center (CC)
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
City of Hope Medical Center
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Assiut University
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
AIDS Malignancy Consortium
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Mayo Clinic
SANGUINE
JaxBio Ltd
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
BELUGA
Munich Leukemia Laboratory
SIRIUS
Munich Leukemia Laboratory
HMvax-Regist
Wake Forest University Health Sciences
DRP_ZH
University Children's Hospital, Zurich
HemaTMA
Tampere University Hospital
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Children's Oncology Group
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
I-PREDICT Heme
University of California, San Diego
AutoCOVID-19
Uppsala University
THERMAL
Malaghan Institute of Medical Research
HemoDiag
University Hospital, Montpellier
SPIEVIE
University Hospital, Toulouse
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
University of Malaya
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Gruppo Italiano Malattie EMatologiche dell'Adulto
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Celgene
Transfusional Iron Overload Among Leukemia Survivors
St. Jude Children's Research Hospital
Fungemia in Hematologic Malignancies
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
Assistance Publique - Hôpitaux de Paris
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Kiadis Pharma
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
University of California, San Francisco
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
University of California, San Francisco
HPDSC
Celgene
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
National Institutes of Health Clinical Center (CC)